H. Weißbrodt

916 total citations
18 papers, 667 citations indexed

About

H. Weißbrodt is a scholar working on Pulmonary and Respiratory Medicine, Surgery and Infectious Diseases. According to data from OpenAlex, H. Weißbrodt has authored 18 papers receiving a total of 667 indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Pulmonary and Respiratory Medicine, 7 papers in Surgery and 6 papers in Infectious Diseases. Recurrent topics in H. Weißbrodt's work include Cystic Fibrosis Research Advances (7 papers), Antifungal resistance and susceptibility (5 papers) and Antibiotic Resistance in Bacteria (5 papers). H. Weißbrodt is often cited by papers focused on Cystic Fibrosis Research Advances (7 papers), Antifungal resistance and susceptibility (5 papers) and Antibiotic Resistance in Bacteria (5 papers). H. Weißbrodt collaborates with scholars based in Germany, United States and Greece. H. Weißbrodt's co-authors include Frauke Mattner, H. von der Hardt, M. Strueber, Burkhard Tümmler, Jens Gottlieb, Tobias Welte, Dietmar Grothues, Gratiana Steinkamp, André Simon and Petra Gastmeier and has published in prestigious journals such as The Lancet, Journal of Clinical Microbiology and Thorax.

In The Last Decade

H. Weißbrodt

17 papers receiving 655 citations

Peers

Countries citing papers authored by H. Weißbrodt

Since Specialization

Citations

This map shows the geographic impact of H. Weißbrodt's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Weißbrodt with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Weißbrodt more than expected).

Fields of papers citing papers by H. Weißbrodt

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Weißbrodt. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Weißbrodt. The network helps show where H. Weißbrodt may publish in the future.

Co-authorship network of co-authors of H. Weißbrodt

This figure shows the co-authorship network connecting the top 25 collaborators of H. Weißbrodt. A scholar is included among the top collaborators of H. Weißbrodt based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Weißbrodt. H. Weißbrodt is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

18 of 18 papers shown

#	Work	Indexed citations
1	Successful prevention of scedosporiosis after lung transplantation in a cystic fibrosis patient by combined local and systemic triazole therapy 2013 ·Medical Mycology Case Reports ·(unknown), Carsten Müller, H. Weißbrodt, Sebastian Suerbaum, Kathrin Tintelnot, (unknown), Gesine Hansen, Ludwig Sedlacek	10
2	Effective prevention of Pseudomonas aeruginosa cross-infection at a cystic fibrosis centre – Results of a 10-year prospective study 2011 ·International Journal of Medical Microbiology ·Lutz Wiehlmann, Nina Cramer, (unknown), Silke Hedtfeld, H. Weißbrodt, Burkhard Tümmler	28
3	271: The Clinical Impact of Non-Aspergillus Mold Colonization in Lung Transplant Recipients (LuTx) 2009 ·The Journal of Heart and Lung Transplantation ·Frauke Mattner, Christine Fegbeutel, H. Weißbrodt, (unknown)	1
4	Impact of graft colonization with gram-negative bacteria after lung transplantation on the development of bronchiolitis obliterans syndrome in recipients with cystic fibrosis 2008 ·Respiratory Medicine ·Jens Gottlieb, Frauke Mattner, H. Weißbrodt, (unknown), Thomas Fuehner, M. Strueber, André Simon, Tobias Welte	91
5	Impact of Bacterial and Fungal Donor Organ Contamination in Lung, Heart–Lung, Heart and Liver Transplantation 2008 ·Infection ·Frauke Mattner, Axel Kola, S. Fischer, Thomas Becker, Axel Haverich, André Simon, Sebastian Suerbaum, Petra Gastmeier, H. Weißbrodt, M. Strüber	29
6	Post-operative Nosocomial Infections After Lung and Heart Transplantation 2007 ·The Journal of Heart and Lung Transplantation ·Frauke Mattner, Stefan Fischer, H. Weißbrodt, Iris F. Chaberny, D. Sohr, Jens Gottlieb, Tobias Welte, Cornelia Henke‐Gendo, Petra Gastmeier, M. Strueber	78
7	Evaluation of the E test for the assessment of synergy of antibiotic combinations against multiresistant Pseudomonas aeruginosa isolates from cystic fibrosis patients 2006 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), Michael Hogardt, Sabine Schmoldt, (unknown), H. Weißbrodt, Susanne Häußler	31
8	178 2006 ·The Journal of Heart and Lung Transplantation ·Frauke Mattner, S. Fischer, H. Weißbrodt, B. Haubitz, Jens Gottlieb, Iris F. Chaberny, André Simon, Petra Gastmeier, M. Strueber	3
9	Surveillance invasiver Fadenpilzmykosen in lungentransplantierten Patienten: Effekt antimykotischer Prophylaxe mit Itraconazol und Voriconazol 2005 ·Mycoses ·Frauke Mattner, Iris F. Chaberny, H. Weißbrodt, (unknown), Petra Gastmeier, B. Haubitz, Jens Gottlieb, Lutz Mattner, M. Strueber	22
10	Comparison of the Micronaut Merlin automated broth microtiter system with the standard agar dilution method for antimicrobial susceptibility testing of mucoid and nonmucoid Pseudomonas aeruginosa isolates from cystic fibrosis patients 2004 ·European Journal of Clinical Microbiology & Infectious Diseases ·(unknown), (unknown), H. Weißbrodt, (unknown)	12
11	Two case reports: Fatal Absidia corymbifera pulmonary tract infection in the first postoperative phase of a lung transplant patient receiving voriconazole prophylaxis, and transient bronchial Absidia corymbifera colonization in a lung transplant patient 2004 ·Scandinavian Journal of Infectious Diseases ·Frauke Mattner, H. Weißbrodt, M. Strueber	40
12	Efficacy of a Benzalkonium Chloride-Impregnated Central Venous Catheter to Prevent Catheter-Associated Infection in Cancer Patients 2000 ·Chemotherapy ·K. Jaeger, (unknown), (unknown), (unknown), (unknown), (unknown), H. Ruschulte, Constanze Kuhlmann, H. Weißbrodt, Arnold Ganser, Meinolf Karthaus	38
13	Epidemiology of chronic Pseudomonas aeruginosa infections in the airways of lung transplant recipients with cystic fibrosis 1997 ·Thorax ·(unknown), Peter Gudowius, (unknown), Ute Römling, H. Weißbrodt, Wolfgang Schürmann, H. von der Hardt, Burkhard Tümmler	78
14	Manifestations of Chlamydia induced arthritis in patients with silent versus symptomatic urogenital chlamydial infection. 1995 ·PubMed ·J. Wollenhaupt, (unknown), H. Weißbrodt, Céline Schneider, (unknown), H. Zeidler	22
15	Genetic determinants of airways' colonisation with Pseudomonas aeruginosa in cystic fibrosis 1993 ·The Lancet ·(unknown), Thilo Dörk, Ulrich Wulbrand, Nanette Kälin, Thomas Neumann, Brigitte Wulf, (unknown), Heinz Geerlings, H. Weißbrodt, H. von der Hardt	79
16	Nosocomial acquisition of Pseudomonas aeruginosa by cystic fibrosis patients 1991 ·Journal of Clinical Microbiology ·Burkhard Tümmler, (unknown), Dietmar Grothues, H. Weißbrodt, Gratiana Steinkamp, H. von der Hardt	103
17	Epidemiology and treatment of gastric Campylobacter pylori infection: more questions than answers. 1990 ·PubMed ·(unknown), J. Freise, Stephan N. Wagner, Bernd Bokemeyer, H. Weißbrodt, (unknown), B. Soudah, (unknown)	1
18	Kalkulierte initiale Chemotherapie bei beatmeten postoperativen Patienten mit Peritonitis, Sepsis bzw. Pneumonie 1986 ·Infection ·(unknown), H. Weißbrodt, Hermann Aebert, H. Bunzendahl	1

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact